A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2019
At a glance
- Drugs Belatacept (Primary) ; Antithymocyte globulin; Methylprednisolone; Mycophenolate mofetil; Prednisone
- Indications Transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 28 Dec 2018 Planned initiation date changed from 15 Nov 2018 to 15 Jan 2019.
- 06 Oct 2018 Planned initiation date changed from 1 Jun 2018 to 15 Nov 2018.
- 05 Jan 2018 New trial record